Seeing Is Believing
RNXT is currently covered by 2 analysts with an average price target of $8.75. This is a potential upside of $8.05 (417.75%) from yesterday's end of day stock price of $1.69.
RenovoRx's activity chart (see below) currently has 5 price targets and 8 ratings on display. The stock rating distribution of RNXT is 100% BUY.
Highest price target for RNXT is $14.5, Lowest price target is $3, average price target is $8.75.
Most recent stock forecast was given by EDWARD WOO from ASCENDIANT on 28-Aug-2026. First documented stock forecast 07-Oct-2021.
Currently out of the existing stock ratings of RNXT, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Jun-2025
$14.5
$12.74 (723.86%)
$13.5
18 days ago
(28-Aug-2026)
0/3 (0%)
$12.83 (768.26%)
Buy Since 27-Mar-2025
$3
$1.24 (70.45%)
$3
5 months 7 days ago
(08-Apr-2026)
0/4 (0%)
$2.06 (219.15%)
Buy Since 02-Nov-2021
$4
$2.87 (253.98%)
2 years 7 months 13 days ago
(02-Feb-2024)
0/2 (0%)
$2.3 (135.29%)
Hold Since 15-Nov-2023
$15
2 years 10 months ago
(15-Nov-2023)
0/2 (0%)
$15 (0.00%)
Which analyst most recently updated their price target on RNXT (RenovoRx)?
Which analyst has the current lower performing score on RNXT (RenovoRx) with a proven track record?
Which analyst has the most public recommendations on RNXT (RenovoRx)?
Which analyst is the currently most bullish on RNXT (RenovoRx)?
Which analyst is the currently most reserved on RNXT (RenovoRx)?